CD274 and neoplasm: Indeed, by binding to Programmed death-1 (PD-1) on tumour-infiltrating T-cells (TILs), PD-L1 inhibits signalling pathways downstream of the T-cell receptor (TCR), thus hindering T-cell proliferation, cytolytic function, and cytokines release [25].